- Home
- About
- 🤖 AskAnzal AI Advisor
- 📅 Book a Call
- Your Account
- My AskAnzal Account
Cases selected for the AskAnzal weekly PMCPA insight newsletter
PMCPA ruled Novartis’ edited Beovu “first experience” HCP video was misleading because it retained positive case outcomes but…
A UCB employee ‘liked’ a third-party LinkedIn post about Bimzelx EU approval. The Panel said a ‘like’ can…
An SMC guidelines summary card for Nilemdo/Nustendi implied use with any statin dose. The simvastatin >40mg contraindication was…
A UK physician alleged a shingles TV ad and linked disease-awareness site indirectly promoted GSK’s Shingrix. PMCPA Panel…
PMCPA found GSK’s Tackle Meningitis site showed substantive desktop vs mobile differences on two pages. Each final form…
Four patient-facing articles funded by a GSK grant disclosed the funding only at the bottom of each page.…
Complaint about Lantus promotional leavepieces and a mailer. Issues included “24-hour efficacy” wording and a hypoglycaemia comparison based…
Bayer Schering was found to have promoted Xarelto (rivaroxaban) before UK authorisation via a UK congress exhibition panel…
Novo Nordisk’s Victoza launch activity led to multiple Code breaches, mainly around misleading claims, lack of balance/safety info,…
Anonymous employee alleged Astellas misled PMCPA about Milan advisory board delegate selection. Panel/Appeal Board found false/incomplete information and…
One real case. One key lesson. Every week — free.